Chesterfield, Missouri — According to state and local development sources, Katalyst Surgical plans to invest $8,080,000.00 to build out 60,000 square feet of new space in Chesterfield. The company plans to occupy the new space at 722 Goddard Ave in Chesterfield, on or about May 1, 2024. According to the company website Katalyst Surgical is the industry leader in ophthalmic surgical instruments. Our experienced team has over 40 years of design, manufacturing, and quality control of ophthalmic surgical products. It is our goal to provide superior service paired with high quality ophthalmic products at a cost saving to our customers. We stand by our company-wide policy that the customer is always right… By continually gathering customer feedback and working with our highly skilled professional team, Katalyst Surgical continues to deliver unmatched ophthalmic instruments while increasing our number of loyal customers. Katalyst Surgical is a premier research and development facility… Keeping up with cutting edge products and the changing industry has allowed us to serve our customers with 100% satisfaction Superior products within your budget… Your business is important to our team at Katalyst Surgical. Our goal is to offer superior products with premium customer service within your budget.

To learn more about Katalyst Surgical, visit http://katalystsurgical.com/

Company Contact:
Franz Grimmeisen, Chief Financial Officer
https://www.linkedin.com/in/dr-franz-p-grimmeisen-7059a2107/
636-536-5950

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.